CSI Biopharmaceutical Manufacturing: How Manufacturing Failures are Investigated Katie Stewart – Technical Training Manager.

Slides:



Advertisements
Similar presentations
Applications of Biotechnological Processes Antibody Production.
Advertisements

Radiopharmaceutical Production
Dock to Stock at Skyline Biotech A brief Outline of how we make our product at Skyline Biotech.
Producing a Pharmaceutical or Biopharmaceutical
Root Cause Analysis for Effective Incident Investigation Christy Wolter, CIH Principal Consultant Environmental and Occupational Risk Management (EORM.
Accident Investigation. What is an Accident? n An unintended happening, mishap. n Most often an accident is any unplanned event that results in personal.
Practical’s. Practical 1 Learning objectives: By the end of the lesson you should be able to State the similarities and differences between animal, plant.
MOLECULAR FARMING.
Drug Delivery & Tissue Engineering Laboratory
World Health Organization
Determining the True Root Cause(s) of Accidents and Safety Incidents Incident Investigation and Analysis.
Bio-manufacturing Overview
Accident Investigation State of Florida Loss Prevention Program.
Food Safety and Sanitation
Biopharmaceutical Products Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 23 rd September,
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Careers in Biotechnology
Pre-AP Biology Ch.12 Ms. Haut
Why Recombine DNA? 1.To produce protein products 2.To alter genetic inheritence (new traits) 3.For diagnostic tests – allows researchers to study causes.
Medical Biotechnology
Good Laboratory Practice
Foundation Degree IT Project Methodologies (for reference)
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Pharmaceutical Biotechnology PHT 426
Biotechnology in Medicine Chapter 12.
CSI Biopharmaceutical Manufacturing: How Manufacturing Failures are Investigated Human Genome Sciences Inc. Katie Stewart – Technical Training Supervisor.
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
ISO NON-CONFORMANCE, CORRECTIVE AND PREVENTIVE ACTION.
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS Dr.G.Hima Bindu MD; PG dip. diabetology Asst.Professor Dept. of Pharmacology Rajiv Gandhi Institute.
Key Area 3: Producing New Cells. Mitosis Why do cells divide? Organisms would only ever exist as single cells – fine for bacteria but not so good for.
Problem Management Scenario # 2 September 17,2005.
Accident Investigation. What is an Accident? n An unintended happening, mishap. n Most often an accident is any unplanned event that results in personal.
2° Partial Project Biotechnology – Genetically modified organisms
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Biotech Vocabulary. AMINO ACID  The building blocks of a protein molecule.  A protein is composed of a chain of hundreds or thousands of amino acids.
ERT 313 BIOSEPARATION ENGINEERING INTRODUCTION
Fermentation Technology
Case Study 3.1 WP Inc MGMT 580 – Quality Management and Statistics Group 3: Cody Groves, Bruce Kastner, & Heather Moore.
Genetic engineering Lesson Objectives Genetic engineering involves changing the genetic material of an organism Genes can be transferred from one organism.
Bioprocessing Bioprocessing deals with the manufacture of biochemicals, biopharmaceuticals, foods, nutraceuticals, and agrochemicals New biologically derived.
Fermentation Fermentation is the term used by microbiologists to describe any process for the production of a product by means of the mass culture of a.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
BIOTECHNOLOGY Gene Sequencing (Human Genome Project) Cloning Stem Cell Research Gene Therapy DNA Fingerprinting (and other Forensics applications)
Upstream Processing Overview
BSB Biomanufacturing CHAPTER 3 Biomanufacturing Processes
VxP Biologics The Biologics Service Company
Quality Control and Assurance
BIOMANUFACTURING Photo from Flickr.com.
Biotechnology R&D.
What are Biopharmaceuticals?
Producing a Pharmaceutical or Biopharmaceutical
Northeast Biomanufacturing Center and Collaborative
What are Biopharmaceuticals?
Membrane protein expression Proteins are the building blocks of all living organisms and play crucial roles in biological processes. To investigate how.
The Lifecycle of Pharmaceutical products
Introduction to the Biotechnology Workplace
Membrane protein expression Proteins are the building blocks of all living organisms and play crucial roles in biological processes. To investigate how.
Introduction to the Biotechnology Workplace
Introduction to GMP.
DO NOW QUESTION Do you think it is ok for humans to modify genes in living organisms? Why or Why not? Campbell 8thed Chapter 20/ Lemur Chapter 12.
Molecular Techniques and Biotechnology
QP FORUM 2018 QP DECISION MAKING.
Root Cause Analysis for Effective Incident Investigation
Biotechnology in North Carolina Today
Presented by: Ken Glade Director of Engineering
Producing a Pharmaceutical or Biopharmaceutical
Producing a Pharmaceutical or Biopharmaceutical
Accident Investigation
Radiopharmaceutical Production
Presentation transcript:

CSI Biopharmaceutical Manufacturing: How Manufacturing Failures are Investigated Katie Stewart – Technical Training Manager

2 Biopharmaceuticals What are Biopharmaceuticals? – Protein or nucleic acid based pharmaceutical therapeutics – Produced by means other than: 1) Direct extraction from a biological source 2) Or chemical synthesis Biopharmaceutical examples – Recombinant protein – Insulin from E.coli – Antisense DNA – blocks protein production – Monoclonal Antibody – to work with immune system

3 Example of an Antibody Pharmaceutical  BENLYSTA is a Monoclonal Antibody  Treatment for Lupus (autoimmune disease)  Controls immune system

4 Various types of cells can be used to produce biopharmaceuticals Mammalian/Animal – typically used for antibody production Yeast Saccharomyces cerevisiae (primarily used by HGS) Pichia pastoris Plant Bacteria Insect How do we create new Biopharmaceuticals?

5 A “gene,” which codes for the drug product (protein or antibody) is inserted into a cell’s DNA Gene Cell Nucleus of cell where the DNA exists

6 The drug product (protein or antibody) is made by the cell using the inserted DNA and the cells machinery (inside the cell) through several steps The cell then secretes the product outside of itself Cell How do we create new Biopharmaceuticals?

Manufacturing Biopharmaceuticals 7 Upstream Production Cells are grown to large quantities to produce a lot of product Downstream (Purification) Product is collected, purified (cleaned) and concentrated (large to small volume) through multiple Cells Product Production

8 Manufacturing Biopharmaceuticals - Upstream Centrifuge Filter Vial Thaw / Inoculum Expansion 500-Liter Bioreactor 50-Liter Bioreactor Filtration Media Prep 5,000-Liter Bioreactor 20,000-Liter Bioreactor Material is Transferred to Purification - “Downstream” START FINISH

What is a Bioreactor? An apparatus for growing organisms (yeast, bacteria, or animal cells) – Controls environment around cells - temperature, pH, and oxygen levels – Create homogeneous environment (same throughout) environment by constantly stirring the contents.

Deviation Investigating in Manufacturing

Deviations Deviation – Any variance that may have the potential to affect the identity, strength, quality or purity of a product – FDA Regulation - thorough deviation investigations must be conducted Why investigate? Consequences of incomplete investigations: – No FDA approval Loss of hundreds (+) jobs Unmet patient needs Impact to shareholders ($$$$$$) – Endangering of patients Impure or potentially dangerous product

Investigation Process Outline 1.Define the problem 2.Brainstorm potential causes 3.Investigate potential causes 4.Identify cause 5.Implement corrections

13 1. Define the Problem 5 Steps to Developing a Problem Describe the problem in terms of 5 factors: 1.What is the problem? 2.Where is it observed? 3.When is (was) it occurring? 4.What is the magnitude of the problem (Trend or Extent)? 5.What might have been the cause?

14 2. Brainstorm Potential Causes Fishbone - Investigation Tool List potential causes under the following 6 categories – Man (& Woman), – Machine, – Mother nature, – Methods, – Materials, – Measures

15 3. Investigate Potential Causes 4. Determine Root Cause From the Fishbone list gather all of the facts to determine whether each item is or is not the root cause Photo(s) Material affected Operator Interviews Equipment Condition and Maintenance Training Records Recent Changes Documentation and Procedures

5. Implementing Corrections Corrective and Preventative Actions – Corrective Action: Corrects the root cause – Preventative Action: Ensure the deviation does not reoccur – Example: A procedure was incorrectly written and caused the test to fail Corrective Action - Revise the procedure Preventative Action - Review all documents in the area to ensure they are accurate and complete

17 Fishbone Example Mother Nature Cleanliness of room Power outage Machine Equipment not sterile Poor equipment condition Broken controller Materials Solution sterility Cell culture sterility Filter integrity Bioreactor Bag & line integrity Measures Temperature probe broken False positive bacteria result Man Procedures weren’t followed Operators were not trained Methods Procedures weren’t clear Process flaw Deviations occurred Problem: The presence of bacteria was found in a sterile cell culture solution in a bioreactor